Articles From: Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing to FNFV Announces Three-Year 10 Million Share Repurchase Program


No New Clinical Studies Requested Environmental Impact Assessment Plan Will be Discussed With FDA Prior to NDA Submission Company to Host Conference Call on Friday, November 7, 2014, at 9 AM Eastern THE WOODLANDS, Texas, Nov.
Sign-up for Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing investment picks
Third Quarter Adjusted EBITDA Increased 38% Over Previous Quarter Increased Quarterly Dividend by 11% TULSA, Okla., Nov.
Sign-up for SemGroup Corporation Reports Third Quarter 2014 Results investment picks
Board of Directors Declares Special Cash Dividend of $0.10 Per Share EVANSTON, Ill., Nov.
Sign-up for Fidus Investment Corporation Announces Third Quarter 2014 Financial Results investment picks
NOVI, Mich.
Sign-up for ITC Declares Dividend to Shareholders investment picks
2014/11/6
- Revenues from liquids grew to 80% of total production revenues - 24 gross Mid-Continent Hunton wells completed or in progress during Q3 - Raised $101.3 million with public offering of common stock - Announces revised 2015 capital budget and financial and operations guidance HOUSTON , Nov.
Sign-up for Gastar Exploration Inc. Reports Third Quarter 2014 Results investment picks
Third quarter net income available to common shareholders totaled $2.0 million Year-to-date earnings totaled $8.3 million, a $4.8 million or 73% increase over the comparable period in 2013 Asset quality initiatives result in 33% decline in non-performing assets over year-end 2013 Year-over-year average core deposit growth exceeds $20 million VIRGINIA BEACH, Va., Nov.
Sign-up for Hampton Roads Bankshares Announces Third Quarter Financial Results investment picks
Consolidated Earnings Per Share of $0.46 Utility and Bank Deliver Solid Results In Line with Expectations Board Declares Dividend of $0.31 Per Share HONOLULU , Nov.
Sign-up for Hawaiian Electric Industries Reports Third Quarter 2014 Earnings investment picks
STAMFORD, Conn., Nov.
Sign-up for Independence Holding Company Announces 2014 Third-Quarter and Nine-Month Results investment picks
http://media.marketwire.com/attachments/200906/438805_alios.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157104&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Alios BioPharma to Present Preclinical Data on Its Anti-HCV Nucleotides AL-335 and AL-516 at the 2014 American Association for the Study of Liver Diseases Annual Meeting investment picks
- GAAP net income $1.84 per share, $1.45 per share excluding adjustments - Servicing $130.8 billion student loans for 5.8 million borrowers under government contract - 32 percent increase in payment processing revenue driven by RenWeb acquisition LINCOLN, Neb.
Sign-up for Nelnet Reports Third Quarter 2014 Results investment picks
HOUSTON , Nov.
Sign-up for Goodrich Petroleum To Present At Upcoming Conferences investment picks
MILPITAS, Calif.
Sign-up for KLA-Tencor Closes Senior Notes Offering investment picks
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers will present data from clinical studies of Soliris ® (eculizumab) in patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening and ultra-rare diseases caused by chronic uncontrolled complement activation, as well as data from the Global aHUS Registry, at the 56 th Annual Meeting of the American Society of Hematology (ASH). Soliris is the first and only approved treatment for PNH and aHUS.
Sign-up for Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting investment picks
Cintas Corporation (Nasdaq:CTAS) announced the sale of its Document Storage and Imaging businesses.
Sign-up for Cintas Corporation Sale of Document Storage and Imaging Businesses investment picks
SurModics, Inc. (NASDAQ: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced results for its fiscal 2014 fourth quarter.
Sign-up for SurModics Reports Fourth Quarter Fiscal 2014 Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157037&ProfileId=051205&sourceType=1 GREAT NECK, NY --
Sign-up for One Liberty Properties, Inc. Reports Third Quarter 2014 Results investment picks
CHATSWORTH, Calif., Nov.
Sign-up for Capstone Turbine Announces Second Quarter Fiscal Year 2015 Operating Results investment picks
Rockwood Holdings, Inc. (NYSE:ROC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.45 per share.
Sign-up for Rockwood Declares Quarterly Cash Dividend investment picks
2014/11/6
Reports Net Income of $11.5 Million or $0.26 Per Diluted Share, and Adjusted EBITDA of $15.9 Million CLAYTON, Mo., Nov.
Sign-up for FutureFuel Releases Third Quarter and Nine Month 2014 Results investment picks
HOUSTON , Nov.
Sign-up for Bristow Group Announces Quarterly Dividend investment picks
The Walt Disney Company (NYSE: DIS) today reported earnings for its fourth quarter and fiscal year ended September 27, 2014.
Sign-up for The Walt Disney Company Reports Fourth Quarter and Full Year Earnings for Fiscal 2014 investment picks
By Jennifer Booton, MarketWatch NEW YORK (MarketWatch) -- Trojans may be lurking on some of the most popular games running on Apple Inc. devices.
Sign-up for UPDATE: Apple malware is lurking on 'Angry Birds' investment picks
ILUVIEN® Received FDA Approval with Commercial Launch Anticipated in the First Quarter of 2015; additional patent granted in U.S. covering formulation through August 2027 $2.4 Million Net Revenue Achieved Through Sales of ILUVIEN in Germany and the United Kingdom; Shipments Up Over 30% in the United Kingdom Alimera Will Host a Conference Call at 4:30 PM ET Today ATLANTA , Nov.
Sign-up for Alimera Sciences Reports Third Quarter 2014 Financial Results investment picks
AUSTIN, Texas , Nov.
Sign-up for Hanger to Reschedule Third Quarter 2014 Earnings Release and Conference Call investment picks
Scorpio Mining Reports Third Quarter 2014 Canada NewsWire TORONTO , Nov.
Sign-up for Scorpio Mining Reports Third Quarter 2014 investment picks
http://media.marketwire.com/attachments/201203/41309_medivation_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156827&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Medivation Reports Third Quarter Financial Results and Provides Corporate Update investment picks
JACKSONVILLE, Fla.
Sign-up for FNFV Announces Three-Year 10 Million Share Repurchase Program investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing to FNFV Announces Three-Year 10 Million Share Repurchase Program
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent